SEC 13F Intelligence

Legal & General Group PLC / PFE

Legal & General Group PLC’s Pfizer Inc Position

Does Legal & General Group PLC own Pfizer Inc (PFE)? Yes43.51M shares worth $1.2B (+0.28% of its 13F portfolio) as of Q1 2026, up from 42.86M shares the prior filed quarter.

Position Value
$1.2B
Q1 2026
Shares
43.51M
% of Portfolio
+0.28%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $1.3BQ4 ’18Q1 ’19: $1.5BQ2 ’19: $1.5BQ3 ’19: $1.3BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $1.2BQ2 ’20: $1.2BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.3BQ2 ’21: $1.5BQ3 ’21: $1.7BQ4 ’21: $2.3BQ4 ’21Q1 ’22: $2.1BQ2 ’22: $2.2BQ3 ’22: $1.8BQ4 ’22: $2.1BQ4 ’22Q1 ’23: $1.7BQ2 ’23: $1.6BQ3 ’23: $1.4BQ4 ’23: $1.4BQ4 ’23Q1 ’24: $1.4BQ2 ’24: $1.3BQ3 ’24: $1.4BQ4 ’24: $1.1BQ4 ’24Q1 ’25: $1.2BQ2 ’25: $932MQ3 ’25: $1.1BQ4 ’25: $1.1BQ4 ’25Q1 ’26: $1.2Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202643.51M$1.2B+0.28%
Q4 202542.86M$1.1B+0.24%
Q3 202541.74M$1.1B+0.24%
Q2 202538.44M$932M+0.23%
Q1 202541.53M$1.2B+0.37%
Q4 202437.86M$1.1B+0.29%
Q3 202446.68M$1.4B+0.28%
Q2 202446.65M$1.3B+0.29%
Q1 202450.76M$1.4B+0.33%
Q4 202349.62M$1.4B+0.37%
Q3 202342.51M$1.4B+0.49%
Q2 202343.84M$1.6B+0.52%
Q1 202341.75M$1.7B+0.61%
Q4 202241.13M$2.1B+0.81%
Q3 202241.81M$1.8B+0.71%
Q2 202242.79M$2.2B+0.79%
Q1 202241.46M$2.1B+0.65%
Q4 202138.59M$2.3B+0.69%
Q3 202138.88M$1.7B+0.54%
Q2 202137.39M$1.5B+0.49%
Q1 202135.96M$1.3B+0.49%
Q4 202036.50M$1.3B+0.53%
Q3 202036.45M$1.3B+0.60%
Q2 202036.98M$1.2B+0.58%
Q1 202036.70M$1.2B+0.70%
Q4 201935.82M$1.4B+0.67%
Q3 201934.94M$1.3B+0.66%
Q2 201934.36M$1.5B+0.80%
Q1 201934.78M$1.5B+0.84%
Q4 201829.47M$1.3B+1.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Legal & General Group PLC’s full portfolio or all institutional holders of PFE.